Cargando…
Use of Autologous Blood Components in Lymphedema Treatment: A Systematic Review
The main benefit of autologous therapies is its easier obtention and relatively lower concerns regarding ethical implications and patient safety. We conducted a systematic review of publications assessing the potential use of blood components (lymphocytes, red blood cells (RBCs), platelet-rich plasm...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cureus
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6822891/ https://www.ncbi.nlm.nih.gov/pubmed/31700741 http://dx.doi.org/10.7759/cureus.5638 |